Similar articles

• Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?

  Nightingale S, Dabis F. Nightingale S, et al. J Trop Pediatr. 2006 Aug;52(4):235-8. doi: 10.1093/tropej/fml033. J Trop Pediatr. 2006. PMID: 16877674 Review. No abstract available.
• A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

  Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators. Moodley D, et al. J Infect Dis. 2003 Mar 1;187(5):725-35. doi: 10.1086/367898. Epub 2003 Feb 24. J Infect Dis. 2003. PMID: 12599045 Clinical Trial.
• Unequal care sustains vertical transmission rate.

  Kasper T. Kasper T. GMHC Treat Issues. 1999 Feb;13(2):11-2. GMHC Treat Issues. 1999. PMID: 11366115
• [AZT and 3TC treatment in a pregnant woman with HIV infection].

  Pardo MJ, Pedrol E, Coll M, Montull S. Pardo MJ, et al. Med Clin (Barc). 1999 Mar 13;112(9):358-9. Med Clin (Barc). 1999. PMID: 10220772 Spanish. No abstract available.
• HIV-1 drug resistance and mother-to-child transmission.

  Morris L, Pillay C, Gray G, McIntyre J. Morris L, et al. SADJ. 2001 Dec;56(12):614-6. SADJ. 2001. PMID: 11887450 Review.